Literature DB >> 12792441

Superior mesenteric vein thrombosis after colectomy for inflammatory bowel disease: a not uncommon cause of postoperative acute abdominal pain.

Alessandro Fichera1, Lawrence A Cicchiello, David S Mendelson, Adrian J Greenstein, Tomas M Heimann.   

Abstract

PURPOSE: Thromboembolism is a significant cause of morbidity and mortality in inflammatory bowel disease. Several prothrombotic conditions have been investigated in inflammatory bowel disease. The aim of this study was to evaluate the incidence of symptomatic postoperative superior mesenteric vein thrombosis in inflammatory bowel disease patients undergoing colonic resections and to identify and characterize their clinical presentation.
METHODS: Between January 1999 and December 2001, 83 consecutive patients undergoing total colectomy for inflammatory bowel disease were studied retrospectively. Patients who developed new-onset postoperative acute abdominal pain were evaluated by CT scan of the abdomen. A complete coagulation profile, including thrombin time, platelet count, protein C, protein S, antithrombin III, homocysteine level, factor V Leiden mutation, plasminogen, and prothrombin G20210A mutation, was obtained in patients diagnosed with superior mesenteric vein thrombosis.
RESULTS: Four patients (4.8 percent; 3 females; 3 patients with ulcerative colitis and 1 with Crohn's colitis) developed symptomatic postoperative superior mesenteric vein thrombosis. Two of these patients had extension of the clot into the portal vein. Their presenting symptom was abdominal pain, with a median interval of ten days from the index surgery. The hematologic workup was negative in three patients, with one heterozygous for prothrombin G20210A mutation. All patients were treated with systemic anticoagulation for at least six months. One ulcerative colitis patient was diagnosed after abdominal colectomy and underwent an uneventful ileal pouch-anal anastomosis after systemic anticoagulation.
CONCLUSION: Postoperative superior mesenteric vein thrombosis is a more frequent occurrence than previously reported in patients with inflammatory bowel disease. Direct surgical trauma to the middle colic veins, with resulting thrombosis, is likely to be the precipitating factor in a borderline intrinsically hypercoagulable environment. All patients became asymptomatic after systemic anticoagulation and recovered uneventfully.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12792441     DOI: 10.1007/s10350-004-6625-y

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  14 in total

1.  Portomesenteric venous thrombosis following major colon and rectal surgery: incidence and risk factors.

Authors:  Kristin A Robinson; Mark E O'Donnell; David Pearson; J Scott Kriegshauser; Melanie Odeleye; Kristen Kalkbrenner; Zachary Bodnar; Tonia M Young-Fadok
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

Review 2.  Comorbidity in inflammatory bowel disease.

Authors:  Antonio López San Román; Fernando Muñoz
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

3.  Effects of dermatan sulfate derivatives on platelet surface P-selectin expression and protein C activity in blood of inflammatory bowel disease patients.

Authors:  Sheng-Li Ji; Hai-Yan Du; Yan-Qing Chi; Hui-Fei Cui; Ji-Chao Cao; Mei-Yu Geng; Hua-Shi Guan
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

4.  Mesenteric vascular thromboembolism in inflammatory bowel disease: a single center experience.

Authors:  Christian S Jackson; Jonathan Fryer; Silvio Danese; Aryvdas Vanagunas; Sharon Polensky; Alan L Buchman
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

Review 5.  Colectomy in patients with acute colitis: a systematic review.

Authors:  P H E Teeuwen; M W J Stommel; A J A Bremers; G J van der Wilt; D J de Jong; R P Bleichrodt
Journal:  J Gastrointest Surg       Date:  2009-01-09       Impact factor: 3.452

6.  Hospitalized ulcerative colitis patients have an elevated risk of thromboembolic events.

Authors:  Jennifer Y Wang; Jonathan P Terdiman; Eric Vittinghoff; Tracy Minichiello; Madhulika G Varma
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

7.  Postoperative portomesenteric venous thrombosis: lessons learned from 1,069 consecutive laparoscopic colorectal resections.

Authors:  Marco E Allaix; Mukta K Krane; Marco Zoccali; Konstantin Umanskiy; Roger Hurst; Alessandro Fichera
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

8.  Combined portal, splenic and mesenteric venous thrombosis in inactive ulcerative colitis with heterozygous mutation in MTHFR gene: A rare case of thrombophilia.

Authors:  Gül Gürsoy; Ahmet Cimbek; Yaşar Acar; Birsen Erol; Hayriye Cankar Dal; Nuray Evrin; Aslı Gungor
Journal:  J Res Med Sci       Date:  2011-11       Impact factor: 1.852

9.  The role of portal vein thrombosis in the clinical course of inflammatory bowel diseases: report on three cases and review of the literature.

Authors:  Emanuele Sinagra; Emma Aragona; Claudia Romano; Simonetta Maisano; Ambrogio Orlando; Roberto Virdone; Lorenzo Tesè; Irene Modesto; Valeria Criscuoli; Mario Cottone
Journal:  Gastroenterol Res Pract       Date:  2012-10-11       Impact factor: 2.260

Review 10.  Inflammatory bowel disease and thrombosis.

Authors:  Ahmet Tezel; Muzaffer Demir
Journal:  Turk J Haematol       Date:  2012-06-05       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.